• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Blood transfusions linked with increased risk of adverse cardiac events following percutaneous coronary intervention

byJohn PrendergassandBrittany Hasty, MD
February 26, 2014
in Cardiology, Chronic Disease, Surgery
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD

1. The overall red blood cell transfusion rate among 1,431 US hospitals was 2.14%.

2. Blood transfusions in percutaneous coronary intervention patients was associated with increased risk of in-hospital events such as myocardial infarction, stroke and death.

Evidence Rating Level: 2 (Good) 

Study Rundown: Patients receive red blood cell transfusions for various reasons including anemia and bleeding. While they can be lifesaving, they are also associated with severe adverse events such as acute hemolytic reactions and transfusion associated acute lung injury. One subset of patients who frequently receive transfusions are those who underwent percutaneous coronary intervention (PCI) for acute myocardial infarction. Currently, there are no guidelines for the administration of transfusions in this patient population. Therefore, this study set out to understand the relationship between blood transfusions and PCI by examining adverse effects as well as transfusion guidelines.

This study revealed variation in transfusion medicine practices for patients undergoing PCI in the United States with more aggressive thresholds for transfusion than others. Most importantly, transfusions in PCI patients were associated with an increased risk of in-hospital adverse events such as myocardial infarction, stroke, or death. Strengths of this study include its large sample size chosen from a great variety of hospitals. This study is limited by its inability to determine the causality of the relationship between transfusions and adverse outcomes. However, it has laid the groundwork for further research geared at discovering the exact cause behind this phenomenon and potentially developing transfusion recommendations.

RELATED REPORTS

The preoperative combination of evolocumab and rosuvastatin may not reduce major adverse cardiovascular events

The efficacy 3 months of dual antiplatelet therapy is similar to 12 months in patients with acute coronary syndrome

2 Minute Medicine Rewind December 29th, 2025

Click to read the study, published today in JAMA

Relevant Reading: Frequency, predictors, and appropriateness of blood transfusion after percutaneous coronary interventions

In-Depth [retrospective cohort study]: This study examined 2,358,711 patients from 1,431 US hospitals. The overall transfusion rate was 2.14%. Those patients who were transfused were more likely to be female, have multiple comorbidities such as diabetics and end-stage renal disease, and/or required the use of an intra-aortic balloon pump. When patients without post-procedure bleeding event were transfused they had an OR of 8.49 for stroke, 4.96 for death, and 2.38 for myocardial infarction (MI). Also, patients with a post-procedure hemoglobin of ³ 15g/dL without post-procedure bleeding had an OR of 10.06 for an adverse outcome (either MI, stroke, or death). Further, regardless of bleeding events and variable hemoglobin levels in some patients, transfusion was associated with increased risk of in-hospital MI (OR 2.60), stroke (OR 7.72), and death (4.63).

More from this author: Reducing surgical complications may increase costs, Protected sleep periods improve intern alertness and sleep duration, ADHD medication decreases rates of criminality in ADHD patients, Low dose aspirin shows net clinical benefit in patients with first unprovoked venous thromboembolism, Rare TREM-2 mutation implicated in Alzheimer’s Disease

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: PCItransfusion
Previous Post

Live MMR vaccine associated with lower hospital admissions for any infection

Next Post

Vaccine protects against hand, foot, and mouth disease in phase 3 trial

RelatedReports

Using HEART score to risk stratify patients with chest pain is safe but underutilized in the ED
Cardiology

The preoperative combination of evolocumab and rosuvastatin may not reduce major adverse cardiovascular events

January 12, 2026
Using HEART score to risk stratify patients with chest pain is safe but underutilized in the ED
Cardiology

The efficacy 3 months of dual antiplatelet therapy is similar to 12 months in patients with acute coronary syndrome

January 12, 2026
Admission may not be needed following sleep apnea surgery
Weekly Rewinds

2 Minute Medicine Rewind December 29th, 2025

January 12, 2026
Lariat device for left atrial appendage exclusion associated with adverse events
Cardiology

Atrial fibrillation risk is high following coronary artery bypass grafting and is low but gradually accumulates following percutaneous coronary intervention

January 13, 2026
Next Post
Vaccine protects against hand, foot, and mouth disease in phase 3 trial

Vaccine protects against hand, foot, and mouth disease in phase 3 trial

Maternal cell-free DNA sequencing superior to standard aneuploidy screening [CARE Study]

Maternal cell-free DNA sequencing superior to standard aneuploidy screening [CARE Study]

Vitamin and supplement data remains limited, may provide no benefit

Insufficient evidence for vitamin supplements in prevention of CVD or cancer

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • An ultrasound test may more reliably detect ovarian cancer in premenopausal women than the Risk of Malignancy Index
  • Chimeric antigen receptor T-cell therapy may induce sustained remission in multirefractory autoimmune hemolytic anemia
  • Neonatal Hyperbilirubinemia and navigating the 2022 AAP guideline updates
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.